22nd Century Group, Inc. XXII
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. We manufacture and distribute the only combustible tobacco products containing minimally or non-addictive levels of nicotine that are authorized by the US Food and Drug Administration (FDA) for retail purchase. We also provide turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands.
We created our flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them decide their consumption of nicotine. VLN® cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering the nicotine drug to addicted smokers, we offer smokers the option to make their own informed and health conscious productive choices, including the choice to avoid addictive levels of nicotine altogether and help adult smokers smoke less.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.6M | $24.4M | $32.2M | $40.5M | $30.9M | $28.1M | $25.8M | $26.4M | $16.6M | $12.3M |
| Cost of revenue | $10.2M | $14.3M | — | — | — | — | $25.8M | $25.5M | $17.3M | $12.7M |
| Gross profit | $7.4M | $10.1M | — | — | — | — | $14.5K | $899.0K | -$707.9K | -$429.7K |
| R&D | $688.0K | $1.1M | $2.6M | $3.6M | $3.9M | — | $8.1M | $15.0M | $3.4M | $2.3M |
| SG&A | $7.6M | $10.3M | $31.1M | $32.2M | $25.9M | $15.0M | $13.0M | $8.6M | $8.3M | $6.2M |
| Total operating expenses | $8.4M | $11.6M | $36.2M | $35.5M | $29.9M | $20.6M | $23.6M | $24.9M | $12.6M | $11.0M |
| Operating income | -$11.6M | -$13.9M | -$44.9M | -$33.6M | -$28.4M | -$19.2M | -$23.6M | -$24.0M | -$13.3M | -$11.4M |
| Interest expense | $1.5M | $2.1M | $9.4M | $55.0K | $58.0K | $72.0K | $56.0K | $11.0K | $29.1K | $37.7K |
| Pre-tax income | -$13.1M | -$15.5M | -$54.6M | -$36.5M | -$32.6M | -$19.7M | -$26.6M | -$8.0M | -$13.0M | -$11.6M |
| Income tax | $28.0K | $30.0K | $47.0K | $21.0K | $14.0K | $38.0K | $0 | $0 | $0 | $0 |
| Net income | -$5.1M | -$15.2M | -$140.8M | -$59.8M | -$32.6M | -$19.7M | -$26.6M | -$8.0M | -$13.0M | -$11.6M |
| EPS, basic | -52.87 | -45,711.05 | -15,925.99 | -4.65 | -0.21 | -0.14 | -0.21 | — | — | — |
| EPS, diluted | -52.87 | -45,711.05 | -15,925.99 | -4.65 | -0.21 | -0.14 | -0.21 | -0.06 | -0.13 | -0.15 |
| Shares, diluted (wtd. avg.) | 184,067 | 557 | 9,467 | 12.9M | 156.2M | 138.8M | 125.9M | 124.3M | 101.2M | 79.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $7.1M | $4.4M | $2.1M | $3.0M | $1.3M | $1.0M | $485.0K | $605.0K | $3.7M | $13.5M |
| Short-term investments | — | — | — | $18.2M | $47.4M | $21.3M | $38.5M | $55.7M | $59.0M | $0 |
| Receivables | $3.6M | $1.7M | $1.7M | $1.4M | $585.0K | $2.2M | $867.0K | $871.3K | $957.1K | $41.0K |
| Inventory | $4.3M | $2.0M | $4.3M | $7.3M | $2.9M | $2.0M | $2.3M | $3.0M | $3.3M | $3.1M |
| Total current assets | $17.6M | $11.5M | $16.3M | $44.6M | $54.4M | $28.3M | $42.7M | $61.2M | $67.6M | $16.8M |
| Property, plant and equipment | $2.4M | $2.8M | $3.4M | $3.7M | $5.8M | $2.5M | $3.7M | $3.3M | $3.3M | $2.4M |
| Goodwill | — | — | $0 | $33.2M | — | — | — | — | — | — |
| Other intangibles | $6.2M | $5.7M | $5.9M | $7.2M | $7.9M | $8.2M | $8.5M | $9.8M | $7.4M | $7.4M |
| Total assets | $27.0M | $21.7M | $27.5M | $114.7M | $76.0M | $51.7M | $69.0M | $77.3M | $79.7M | $27.6M |
| Accounts payable | $1.0M | $2.4M | $4.4M | $2.1M | $2.2M | $1.1M | $2.0M | $2.6M | $2.1M | $1.3M |
| Short-term debt | — | $1.5M | $5.8M | — | — | — | — | — | — | — |
| Total current liabilities | $7.3M | $10.0M | $25.0M | $13.0M | $8.4M | $7.3M | $5.8M | $5.2M | $4.3M | $3.2M |
| Long-term debt | $708.0K | $5.2M | $8.1M | $3.9M | — | — | — | — | — | — |
| Total liabilities | $8.5M | $17.7M | $35.9M | $18.7M | $9.9M | $7.6M | $6.9M | $6.0M | $4.3M | $3.3M |
| Retained earnings | -$398.9M | -$393.9M | -$378.7M | -$237.8M | -$178.0M | -$145.4M | -$125.7M | -$99.1M | -$91.2M | -$78.1M |
| Total equity | $15.8M | $4.0M | -$8.4M | $96.0M | $66.1M | $44.1M | $62.0M | $71.3M | $75.4M | $24.3M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.7M | -$14.3M | -$55.0M | -$51.7M | -$22.8M | -$15.6M | -$14.6M | -$17.8M | -$12.1M | -$9.9M |
| Depreciation and amortisation | $479.0K | $585.0K | $852.0K | $673.0K | $1.2M | $688.0K | $589.0K | $523.0K | $849.0K | $744.2K |
| Stock-based compensation | $421.0K | $380.0K | $2.7M | $5.5M | $4.0M | $1.7M | $3.5M | $3.2M | $941.6K | $880.5K |
| Capital expenditure | $61.0K | $141.0K | $4.7M | $3.7M | $745.0K | $54.0K | $527.0K | — | — | — |
| Investing cash flow | -$505.0K | -$139.0K | $16.8M | $22.6M | -$27.7M | $16.5M | $4.6M | $15.1M | -$60.6M | -$553.8K |
| Financing cash flow | $11.0M | $16.8M | $37.2M | $30.8M | $50.9M | -$304.0K | $9.9M | -$355.0K | $62.8M | $20.1M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-019610.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.3M | $16.6M | $26.4M | $25.8M | $28.1M | $30.9M | $40.5M | $32.2M | $24.4M | $17.6M |
| Gross profit | -$429.7K | -$707.9K | $899.0K | $14.5K | — | — | — | — | $10.1M | $7.4M |
| Net income | -$11.6M | -$13.0M | -$8.0M | -$26.6M | -$19.7M | -$32.6M | -$59.8M | -$140.8M | -$15.2M | -$5.1M |
Recent filings and events
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
- Shareholder vote Item 5.07
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Material agreement signed Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Unregistered share sale Item 3.02
- Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
- Shareholder rights changed Item 3.03
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2111
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PM | Philip Morris International Inc. | $310.90B | 27.5x | 7.3% |
| MO | ALTRIA GROUP, INC. | $124.08B | 18.0x | -3.1% |
| ISPR | Ispire Technology Inc. | $78.1M | — | -16.1% |
| BTI | British American Tobacco p.l.c. | — | — | — |
| RLX | RLX Technology Inc. | — | — | 50.3% |